Perigon Wealth Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-16,034
Closed -$49K 392
2020
Q2
$49K Hold
16,034
0.01% 354
2020
Q1
$62K Sell
16,034
-48,313
-75% -$3.8M 0.01% 312
2019
Q4
$22K Hold
64,347
﹤0.01% 269
2019
Q3
$40K Hold
64,347
0.01% 238
2019
Q2
$101K Buy
+64,347
New +$4.93M 0.02% 239

Other funds holding MRK

Perigon Wealth Management's MRK Position: Q1 2026 in Review

Perigon Wealth Management increased its Merck (MRK) stake by 1.4% in Q1 2026, buying an estimated $125K and bringing the position to 80,209 shares worth $9.65M. The position accounts for 0.18% of the portfolio, ranked #122.

Perigon Wealth Management first reported a position in MRK in Q4 2013 and has held it in 50 quarters since. The position peaked at $22.6M in Q2 2016. 3,777 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Perigon Wealth Management held 80,209 shares of Merck worth $9.65M as of Q1 2026.
  • Perigon Wealth Management bought 1,081 Merck shares in Q1 2026, an estimated $125K.
  • Merck made up 0.18% of Perigon Wealth Management's portfolio in Q1 2026, its #122 holding.
  • Perigon Wealth Management first reported a position in Merck in Q4 2013 and has held it in 50 quarters since.
  • Perigon Wealth Management's Merck position peaked at $22.6M in Q2 2016.
  • 3,777 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Perigon Wealth Management's 13F filing for Q1 2026, filed 10 Apr 2026.